The Public Health Agency of Canada reported that 18,000 Canadians contracted drug-resistant infections while in hospital. Approximately, 8500 Canadians die from post-operative infections every year.
There is nothing like the IOTEX™ NanoBubbler presently in use. The IOTEX™ NanoBubbler is the solution to the problem of effectively treating at-risk patients who are suffering from topical and other infections.
The IOTEX™ NanoBubbler is a patented machine that infuses water with a safe, anti-infection ingredient:
- chemistry that is safe for people, deadly for microbes.
- different-sized IOTEX™ NanoBubbler machines can be made depending on need.
IOTEX™ has created a number of topical, anti-infection products from a resin originally used in the Space Shuttle to treat water.
IOTEX™ products, in vitro, kill all tested pathogens, including, methicillin- resistant bacteria (MRSA) and pseudomonas aeruginosa, etc.
The IOTEX™ NanoBubbler, uniquely,
- decreases inflammation and therefore decreases pain when treating wounds
- can be used to treat diabetic sores and thereby prevent amputations and/or deaths - can be used to treat burn victims
- can be used to treat athlete’s foot infections
- can be used to ameliorate the symptoms of psoriasis
- can be used to ameliorate the symptoms of eczema
- may be an effective treatment for shingles
The IOTEX™ NanoBubbler can be modified to be used in agriculture:
- to prevent and control the spread of infections between cattle, sheep and pigs
- to treat lower leg infections in horses
- in abattoirs to decrease the possibility of contamination
- in aquaculture instead of antibiotics
The IOTEX™ NanoBubbler can be used by veterinarians to treat skin infections and hair problems in dogs and cats. IOTEX™ products do not damage the environment.
IOTEX™ products have had limited use in vivo; however, in post-earthquake Haiti, for example, they proved to be extremely effective.
IOTEX™ products, depending on the situation, can cost less than a penny per use. IOTEX™ products, after thirty years in use, have never encountered bio-resistance.
There is a vast market that needs the IOTEX™ NanoBubbler and other IOTEX™ products, for example:
- there are approximately 6000 medical centers in North America
- there are approximately 6600 veterinarian medical facilities in North America
Retail price for a hospital-sized IOTEX™ NanoBubbler is less than $7,500.00. Replacement cost for the active ingredients is $1,000.00 per year, per unit. There will be a 10% discount for clients who return the active ingredient cartridges.
In a hospital setting, depending on the number of patients treated per day, the per patient cost during the first year would be $5 or less, decreasing to $0.50 or less, beginning in the second year.
To treat a chronic wound in Canada presently costs between $10,000 and $17,000 per year. To close a chronic wound, presently takes approximately 165 days.
The IOTEX™ NanoBubbler and the IOTEX™ Anti-Infection Fabric can dramatically decrease the costs and the treatment times.
Diabetes alone, costs Canada approx. $7 billion per year
- in direct hospital costs
- cardiovascular disease treatment
- G.P. costs
- specialist costs
- medication costs
The IOTEX™ NanoBubbler can have a major impact on 4 of those 5 treatment costs.
More importantly, the IOTEX™ NanoBubbler can decrease up to a 75% of the amputations caused by diabetic infections.
The IOTEX™ Nano-Spray and IOTEX™ Anti-Infection Fabric can be used on small or large cuts, to prevent them from becoming life-threatening conditions.
The IOTEX™ Nano-Spray can be used as a hand and face sanitizer to replace triclosan and/or alcohol wipes
According to the World Health Organization, approx. 347,000,000 people worldwide have diabetes, and the numbers are increasing.
Using IOTEX™ products can help reduce the growth of DRI’s (drug resistant infections)
U.S. patents on the key components.
Resources
IOTEX™ Bubbler-Lab Tests (July 2, 2018) - PDF